Balyasny Asset Management
LUXAW

Balyasny Asset Management’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Balyasny Asset Management’s Portfolio LUXAW Stock Details LUXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-414,170
Closed -$56K – 3552
2022
Q3 		$56K Hold
414,170
– – ﹤0.01% 2468
2022
Q2 		$55K Hold
414,170
– – ﹤0.01% 2348
2022
Q1 		$174K Hold
414,170
– – ﹤0.01% 2049
2021
Q4 		$352K Hold
414,170
– – ﹤0.01% 1706
2021
Q3 		$476K Hold
414,170
– – ﹤0.01% 1493
2021
Q2 		$547K Buy
414,170
+191,548
+86% +$254K ﹤0.01% 1531
2021
Q1 		$332K Buy
+222,622
New +$561K ﹤0.01% 1480

Balyasny Asset Management's LUXAW Position: Q4 2022 in Review

Balyasny Asset Management sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 414,170 shares — an estimated $56K sold.

Balyasny Asset Management first reported a position in LUXAW in Q1 2021 and held it in 7 quarters. The position peaked at $547K in Q2 2021. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

  • Balyasny Asset Management reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 414,170 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $56K.
  • Balyasny Asset Management first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 7 quarters.
  • Balyasny Asset Management's Lux Health Tech Acquisition Corp. Warrants position peaked at $547K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.